Clinical Trial Update: Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the safety and immunogenicity of the PfAMA-1-FVO[25-545] malaria vaccine candidate. The trial is sponsored by the African Malar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfAMA-1-FVO[25-545] vaccine (Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]) vaccine)

Snippet

Sponsor: African Malaria Network Trust | Conditions: Malaria | Phase 1 | Status: UNKNOWN